IceCure Medical Ltd (NASDAQ:ICCM – Get Rating) shares fell 3% during mid-day trading on Monday . The company traded as low as $1.30 and last traded at $1.30. 137,650 shares traded hands during trading, a decline of 76% from the average session volume of 566,353 shares. The stock had previously closed at $1.34.
Analyst Ratings Changes
Separately, Maxim Group began coverage on IceCure Medical in a research note on Tuesday, October 25th. They set a "buy" rating and a $3.00 target price for the company.
Get IceCure Medical alerts:IceCure Medical Trading Down 3.0 %
The company has a 50 day moving average of $1.26 and a 200 day moving average of $1.39. The company has a current ratio of 4.22, a quick ratio of 3.58 and a debt-to-equity ratio of 0.03. The firm has a market cap of $59.31 million, a price-to-earnings ratio of -2.89 and a beta of -0.22.
IceCure Medical (NASDAQ:ICCM – Get Rating) last released its earnings results on Monday, December 5th. The company reported ($0.11) earnings per share for the quarter. The firm had revenue of $0.63 million for the quarter. IceCure Medical had a negative return on equity of 77.00% and a negative net margin of 462.46%. As a group, research analysts anticipate that IceCure Medical Ltd will post -0.42 EPS for the current year.Institutional Inflows and Outflows
A hedge fund recently bought a new stake in IceCure Medical stock. JPMorgan Chase & Co. purchased a new stake in shares of IceCure Medical Ltd (NASDAQ:ICCM – Get Rating) in the 2nd quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission (SEC). The institutional investor purchased 7,240 shares of the company's stock, valued at approximately $78,000.
About IceCure Medical
(Get Rating)
IceCure Medical Ltd, a medical device company, engages in the research, development, and commercialization of medical devices for cryoablation (freezing) of tumors in the human body. It offers ProSense system, a cryoablation solution for the treatment of breast tumors. The company was incorporated in 2006 and is headquartered in Caesarea, Israel.
Featured Articles
- Get a free copy of the StockNews.com research report on IceCure Medical (ICCM)
- Why Gold Can Be A Glistening Addition To Your Portfolio Right Now
- SoFi Technologies Smashes Earnings but Beware the Fed Decision
- Buying The Dip In Colgate-Palmolive
- Mullen Automotive On Hiring Spree, What Could That Mean?
- InterDigital Raises Its Earnings Guidance
Receive News & Ratings for IceCure Medical Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for IceCure Medical and related companies with MarketBeat.com's FREE daily email newsletter.